Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial

…, D Bhowmik, JS Vasudevan, R Maurya, A Kanakan… - MedRxiv, 2020 - medrxiv.org
Introduction A single center open label phase II randomised control trial was done to assess
the pathogen and host-intrinsic factors influencing clinical and immunological benefits of …

COVID-19 Risk Stratification and Mortality Prediction in Hospitalized Indian Patients: Harnessing clinical data for public health benefits

S Alle, A Kanakan, S Siddiqui, A Garg, A Karthikeyan… - PLoS …, 2022 - journals.plos.org
The variability of clinical course and prognosis of COVID-19 highlights the necessity of patient
sub-group risk stratification based on clinical data. In this study, clinical data from a cohort …

FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip

…, S Acharya, M Azhar, J Murthy, P Kathpalia, A Kanakan… - Elife, 2021 - elifesciences.org
The COVID-19 pandemic originating in the Wuhan province of China in late 2019 has impacted
global health, causing increased mortality among elderly patients and individuals with …

[HTML][HTML] Clinical, serological, whole genome sequence analyses to confirm SARS-CoV-2 reinfection in patients from Mumbai, India

…, M Pathak, S Chaudhary, C Sharma, A Kanakan… - Frontiers in …, 2021 - frontiersin.org
Background: SARS-CoV-2 infection may not provide long lasting post-infection immunity.
While hundreds of reinfections have reported only a few have been confirmed. Whole genome …

A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

…, A Lahiri, JS Vasudevan, R Maurya, A Kanakan… - Nature …, 2022 - nature.com
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …

Whole genome sequencing confirmed SARS-CoV-2 reinfections among healthcare workers in India with increased severity in the second episode

…, N Chatterjee, M Pathak, C Sharma, A Kanakan… - 2020 - papers.ssrn.com
Background: Frontline healthcare workers (HCWs) are exceedingly exposed to SARS-CoV-2
and reinfections are a possibility. A RT-PCR positive test does not confirm reinfection. …

Increased abundance of Achromobacter xylosoxidans and Bacillus cereus in upper airway transcriptionally active microbiome of COVID-19 mortality patients indicates …

…, A Yadav, P Chattopadhyay, A Kanakan… - Microbiology …, 2022 - Am Soc Microbiol
The modulators of severe COVID-19 have emerged as the most intriguing features of SARS-CoV-2
pathogenesis. This is especially true as we are encountering variants of concern (…

[HTML][HTML] SARS-CoV-2 mutations and COVID-19 clinical outcome: mutation global frequency dynamics and structural modulation hold the key

…, A Swaminathan, V Ravi, S Saifi, A Kanakan… - Frontiers in Cellular …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had an enormous
burden on the healthcare system worldwide, as a consequence of its new emerging variants of …

Threading the pieces together: integrative perspective on SARS-CoV-2

A Kanakan, N Mishra, J Srinivasa Vasudevan, S Sahni… - Pathogens, 2020 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
challenged the research community globally to innovate, interact, and integrate findings across …

[HTML][HTML] Geographical landscape and transmission dynamics of SARS-CoV-2 variants across India: a longitudinal perspective

N Jha, D Hall, A Kanakan, P Mehta, R Maurya… - Frontiers in …, 2021 - frontiersin.org
Globally, SARS-CoV-2 has moved from one tide to another with ebbs in between. Genomic
surveillance has greatly aided the detection and tracking of the virus and the identification of …